These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15503050)

  • 21. Diabetic retinopathy: a review of general medical factors in patient care.
    Begg IS
    Can J Ophthalmol; 1984 Jun; 19(4):159-68. PubMed ID: 6744100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Care of vision and ocular health in diabetic members of a national diabetes organization: a cross-sectional study.
    Sundling V; Gulbrandsen P; Jervell J; Straand J
    BMC Health Serv Res; 2008 Jul; 8():159. PubMed ID: 18655733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospects for angiotensin receptor blockers in diabetic retinopathy.
    Sjølie AK
    Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short report: suboptimal diabetes care in high-risk diabetic patients attending a specialist retina clinic.
    Al-Ansari SA; Tennant MT; Greve MD; Hinz BJ; Senior PA; Hanson CP
    Diabet Med; 2009 Dec; 26(12):1296-300. PubMed ID: 20002485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between retinopathy and glycaemic control in insulin-dependent and non-insulin-dependent diabetes.
    Monson JP; Koios G; Toms GC; Kopelman PG; Boucher BJ; Evans SJ; Alexander WL
    J R Soc Med; 1986 May; 79(5):274-6. PubMed ID: 3723520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.
    Wang B; Wang F; Zhang Y; Zhao SH; Zhao WJ; Yan SL; Wang YG
    Lancet Diabetes Endocrinol; 2015 Apr; 3(4):263-74. PubMed ID: 25660574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between diabetic retinopathy and systemic risk factors.
    Wat N; Wong RL; Wong IY
    Hong Kong Med J; 2016 Dec; 22(6):589-99. PubMed ID: 27779095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus.
    Müller M; Schönfeld CL; Grammer T; Krane V; Drechsler C; Genser B; Kohnen T; Wanner C; März W
    Sci Rep; 2020 Aug; 10(1):14158. PubMed ID: 32843669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diabetic retinopathy].
    Körner F; Pournaras C
    Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1205-7. PubMed ID: 2237047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.
    Aiello LP; Ayala AR; Antoszyk AN; Arnold-Bush B; Baker C; Bressler NM; Elman MJ; Glassman AR; Jampol LM; Melia M; Nielsen J; Wolpert HA;
    JAMA Ophthalmol; 2015 Aug; 133(8):888-96. PubMed ID: 25996273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and risk factors for diabetic retinopathy in Asian Indians with young onset type 1 and type 2 diabetes.
    Rajalakshmi R; Amutha A; Ranjani H; Ali MK; Unnikrishnan R; Anjana RM; Narayan KM; Mohan V
    J Diabetes Complications; 2014; 28(3):291-7. PubMed ID: 24512748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vascular complications of diabetes: is there a glycemic threshold?].
    Isnard F; Eschwège E
    Rev Prat; 2001 Oct; 51(16):1759-64. PubMed ID: 11795118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is intensive management of blood pressure to prevent visual loss in persons with type 2 diabetes indicated?
    Klein R
    Arch Ophthalmol; 2004 Nov; 122(11):1707-9. PubMed ID: 15534135
    [No Abstract]   [Full Text] [Related]  

  • 35. Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition.
    Chaturvedi N; Fuller JH; Pokras F; Rottiers R; Papazoglou N; Aiello LP;
    Diabet Med; 2001 Apr; 18(4):288-94. PubMed ID: 11437859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Summary of randomized trials of angiotensin converting enzyme inhibitors.
    Yusuf S; Lonn E; Bosch J; Gerstein H
    Clin Exp Hypertens; 1999; 21(5-6):835-45. PubMed ID: 10423106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accepting diabetes and denying blindness ... as seen through a juvenile's eyes.
    Uzzle M
    Insight; 2009; 34(4):19-20. PubMed ID: 20000134
    [No Abstract]   [Full Text] [Related]  

  • 38. Diabetes and hypertension. What is new?
    Barrios V; Escobar C
    Minerva Cardioangiol; 2009 Dec; 57(6):705-22. PubMed ID: 19942843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of the United Kingdom Prospective Diabetes Study (UKPDS) results on patient management.
    Nicollerat JA
    Diabetes Educ; 2000; 26 Suppl():8-10. PubMed ID: 11912816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of retinopathy in patients with type 1 diabetes treated with education-based intensified insulin therapy and its association with parameters of glucose control.
    Hatz K; Minder AE; Lehmann R; Drescher T; Gerendas B; Schmidt-Erfurth U; Kaider A; Pruente C; Zulewski H
    Diabetes Res Clin Pract; 2019 Feb; 148():234-239. PubMed ID: 30684505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.